Innovative new technologies like iSWEEP, embodied in iART and iDVT, clearly demonstrate that peripheral thrombectomy does not have to compromise. No longer do practitioners need to live with the inherent shortcomings of existing aspiration systems, metal draggers, or lytic therapy approaches.
Using a proven mechanism of action that mirrors the 60 year surgical Fogarty experience long proven to be effective and safe on vessels, this no compromise approach addresses shortcomings of blood loss, vessel damage, valve damage, distal embolization, and cost.
For physicians and hospitals, this design delivers several concrete advantages:
- Non-surgical, non-drug therapy: avoids surgical and drug complications and reduces length of stay (LoS).
- Controlled flow and embolic protection: proximal + distal balloon and funnel configuration reduce distal embolization.
- Vessel and valve preservation: compliant balloon sweep is intended to avoid endothelial scarring and valve damage common with rigid metal draggers.
- Minimal blood loss: flow arrest and proven mechanism of action result in low estimated blood loss (EBL) in clinical use.
- Workflow simplicity: all components are in one disposable system, no capital equipment, straightforward setup that fits standard endovascular workflows.
To learn more, read this new paper on No Compromise Approach to Peripheral Thrombectomy
